LncRNA IGFBP7-AS1 facilitates gastric cancer cell aggressiveness and is associated with poor prognosis via miR-216a-5p-mediated NF-κB activation
Objective This study aimed to elucidate the clinical significance and molecular mechanisms of lncRNA IGFBP7-AS1 in gastric cancer progression. Methods IGFBP7-AS1 expression levels were examined using the GSE174237 dataset, followed by validation in 115 pairs of gastric cancer specimens and their corresponding non-cancerous counterparts. Kaplan-Meier and Cox regression analyses were employed to evaluate its prognostic significance. Functional experiments were conducted in gastric cancer cell lines. The interaction between IGFBP7-AS1 and miR-216a-5p was confirmed, and the activation status of the NF-κB signaling cascade was examined. Results IGFBP7-AS1 transcript levels were markedly elevated in both gastric cancer specimens and cell lines relative to controls. Upregulation of IGFBP7-AS1 positively correlated with lymph node involvement ( P = 0.016), disease stage advancement (III–IV, P = 0.006), and diminished overall survival ( P < 0.001), with multivariate analysis showing that high IGFBP7-AS1 expression was independently associated with adverse outcomes in this cohort ( P = 0.002). Additionally, IGFBP7-AS1 silencing substantially impaired gastric cancer cell growth, motility, and tissue invasiveness. IGFBP7-AS1 was found to negatively associate with miR-216a-5p. Rescue experiments demonstrated that knockdown of IGFBP7-AS1 led to reduced phosphorylation ratios of p65, IκBα, and IKKβ, whereas co-inhibition of miR-216a-5p partially restored these phosphorylation levels. Conclusions IGFBP7-AS1 was associated with shorter overall survival in our cohort and promotes gastric cancer progression at least in part by sponging miR-216a-5p and activating the NF-κB signaling pathway. These findings suggest IGFBP7-AS1 as a potential prognostic biomarker and a possible therapeutic target, but its clinical utility requires further validation in a larger, multicenter, prospective cohort.
Authors
- Zheng He (ORCID: https://orcid.org/0000-0002-4861-7590)
- Zhisheng Xia
- Junxiong Deng
- Guanhui He
- Huiling Qin
- Keyu Zhou
- Meng Tian
Publication Details
- Journal
- Hereditas
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1186/s41065-026-00764-w
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00